Pharmstandard International S.A., 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 72,136 shares at $4.60 ($328K) on 2016-09-29, disclosed to the SEC on 2016-09-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.54 | 28,518 | $129K | 39.4% |
| 2 | $4.54 | 28,518 | $129K | 39.4% |
| 3 | $4.60 | 15,100 | $69K | 21.2% |
| Total | $4.55 avg | 72,136 | $328K | 100% |
| Filing → |
| ARGS | BUY | 2016-08-29 | $252K | — | Filing → |
| ARGS | BUY | 2016-08-25 | $305K | — | Filing → |
| ARGS | BUY | 2016-08-23 | $320K | — | Filing → |